MEDIQUELL
Dead / Abandoned — Abandoned — no statement of use filed (as of 17 Jun 2024)
What this means for you
This application is over — abandoned 17 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97656194
- Mark type
- Stylized text
- Filed
- 31 Oct 2022
- Published for opposition
- 19 Sept 2023
- Abandoned
- 17 Jun 2024
- Attorney of record
- David W. Osborne
Goods and services
- Class 005 — Pharmaceuticals: Oral dosage formulations for use as pharmaceuticals, nutraceuticals, and dietary supplements, taking the form of liquids, syrups, beads, granules, solid tablets, chewable tablets, dissolvable tablets, confections, lozenges, and gum for treatment or prevention of diseases and conditions in the oral cavity, the nasal passages and sinuses, the throat, the respiratory system, the gastrointestinal tract, the endocrine system, the cardiovascular system, the lymphatic system, the nervous system, the skeletal system, the muscular system, the urinary system, or the reproductive system, including symptoms of viral or bacterial infections of the foregoing systems, namely, cough, nasal congestion, runny nose, post-nasal drip, chest congestion, fever, aches, pain, dyspepsia, diarrhea, heartburn, gastroesophageal reflux disease (GERD), and symptoms of autoimmune conditions and disorders, namely, allergies, diabetes, Crohn's disease, fibromyalgia, Addison disease, Celiac disease, and lactose intolerance
Owner
- Venkor Corporation, Hagerstown, MD, US
- Venkor Corporation, Hagerstown, MD, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 17 Jun 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION
- 30 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2023 — ASSIGNED TO EXAMINER
- 03 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Nov 2022 — NEW APPLICATION ENTERED